# SmartTools Batch 23 — Tool 025 Medication & Compound Session List

**Date:** 2026-10-25 (Africa/Cairo)  
**Status:** `IMPLEMENTED — REVIEW REQUIRED`  
**Git snapshot before this batch:** branch `main`; HEAD `254ce1299bff227c54809bb7027f9b587d69c143`; 718 `git status --short` records; staged diff empty.  
**Git snapshot after implementation and report updates:** branch and HEAD unchanged; 724 `git status --short` records; staged diff remains empty. Existing unrelated and previously untracked files were preserved.  
**Scope:** Tool 025 only. ID, slug, category, route, and ordering remain unchanged.

## Audit finding

The previous implementation generated pairwise interaction classifications from broad traits such as shared family, lipophilicity, and target labels rather than a validated drug-interaction source. It presented those unsupported values as severity, “safety score,” and monitoring/treatment recommendations. Its UI also seeded a default testosterone entry and used `useUserToolState('user-id')`/`useUpdateToolState()` to persist health-related input without an explicit consent or account-isolation contract. The “current medications” field was read-only and did not provide actual medication input.

## Changes

- Replaced the unsupported analyzer with a bilingual **Medication & Compound Session List**. It accepts only user-entered names, item type, optional label/dose text, optional source label, and optional notes.
- Added strict schemas for supported item types, UUID entry IDs, field lengths, unique IDs, and a maximum of 50 entries. The engine validates its input boundary and returns a `USER_PROVIDED` session envelope with `interactionAssessment: NOT_AVAILABLE` and reason `NO_VALIDATED_INTERACTION_SOURCE_CONFIGURED`.
- Removed default medication/compound values, age/weight/health-condition inference, pairwise rules, severity counts, safety score, recommendations, and claims that combinations have no major signal.
- Removed persistence hooks and all local/session storage. Entries exist in React page state only; clear/remove actions discard them. No Supabase or cross-tool data access was added.
- The interface explicitly says that it does not check or predict interactions, assess combination safety, diagnose, or recommend treatment, and directs users to ask a licensed pharmacist or prescriber for an interaction review.
- Updated visible registry/catalog titles and descriptions while preserving Tool 025 identity, order, and route.

No external interaction reference is claimed or used: no validated interaction source/rules are configured in this repository path, so the feature reports assessment unavailable rather than fabricating one.

## Changed artifacts

- `components/tools/tool-025-drug-interaction-pro.tsx`
- `i18n/tool-025-drug-interaction-pro.json`
- `lib/tools/engines/tool-025-drug-interaction-pro.ts`
- `lib/tools/engines/tool-025-drug-interaction-pro.test.ts`
- `lib/tools/schemas/tool-025-drug-interaction-pro.ts`
- `lib/tools/schemas/tool-025-drug-interaction-pro.test.ts`
- `tests/unit/components/tool-025-medication-session-log.test.tsx`
- `lib/tools/smartToolsCatalog5.ts` (Tool 025 catalog entry)
- `lib/tools/registry.ts` (Tool 025 visible title; other local changes preserved)
- `SMARTTOOLS_BATCH_23_REPORT.md`
- `SMARTTOOLS_252_MASTER_INVENTORY.md` (batch addendum)

## Verification evidence

| Command | Result |
|---|---|
| `npx vitest run --project node lib/tools/engines/tool-025-drug-interaction-pro.test.ts lib/tools/schemas/tool-025-drug-interaction-pro.test.ts` | `PASS`, exit 0; 2 files, 6 tests. |
| `npx vitest run --project jsdom tests/unit/components/tool-025-medication-session-log.test.tsx` | `PASS`, exit 0; 1 file, 2 tests, including Arabic RTL and session-only behavior. |
| Scoped `npx eslint --no-ignore` over Tool 025 component, tests, schema, engine, catalog, and registry files | `PASS`, exit 0; no warnings. |
| `npx tsc --noEmit` | `PASS`, exit 0. |
| `npm run validate-tools` | `PASS`, exit 0; 1 file, 5 tests. |
| `npm run build` | `PASS`, exit 0; Next.js generated 389/389 pages. Existing stale Browserslist and missing `metadataBase` warnings remain. Build output reports Supabase configuration, but this batch made no Supabase/database calls. |
| `npx vitest run` | `FAIL`, exit 1; 429 files: 421 passed, 7 failed, 1 skipped; 4,367 passed, 16 failed, 5 skipped (4,388 total). The same seven checkout/payment files and 16 failures documented in Batches 21–22 remain. |
| Build manifest check: `rg -n 'tool-025-drug-interaction-pro' .next/server/app-paths-manifest.json` | `PASS`, exit 0; `/smarttools/tool-025-drug-interaction-pro/page` maps to the existing app route. |
| `git diff --check` on Tool 025 source paths | `PASS`, exit 0; Git displayed the existing CRLF-to-LF warning for the broadly modified `lib/tools/registry.ts`. |

The complete suite's unchanged blockers include missing Fourthwall product mapping for tier `digital`, payment receipt route/test contract mismatches, and related merchant/checkout assertions. This batch did not change any payment files and added eight passing tests while the same 16 failures remained. The repository is not globally green.

## Limits and decision

- This implementation is a temporary record list, not an interaction checker. A future real interaction feature requires a separately reviewed, validated source/service, supported item coverage, update/version handling, data minimization, and a safety contract before it may make interaction claims.
- User-entered contents are not independently verified. They remain only in component memory and are lost when the page unmounts or reloads.
- No database writes, migrations, staging, commit, push, or deployment were performed.

**Decision:** Tool 025's session-list scope is ready for owner review. The original interaction-assessment capability is explicitly `NOT_AVAILABLE`. Overall SmartTools readiness remains `NOT READY` because the full test suite and wider audit still have unresolved blockers.
